Efficacy News and Research

RSS
Immune responses in Omicron breakthrough COVID-19

Immune responses in Omicron breakthrough COVID-19

Gaseous ozone is effective for SARS-CoV-2 disinfection

Gaseous ozone is effective for SARS-CoV-2 disinfection

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Evidence that monoclonal antibodies can reduce COVID-19 (Delta) mortality

Effects of post-acute COVID-19 on physical and mental health in women

Effects of post-acute COVID-19 on physical and mental health in women

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Meta-analysis confirms complete failure of hydroxychloroquine/chloroquine as a COVID-19 treatment

Quantification of SARS-CoV-2 variants in wastewater samples

Quantification of SARS-CoV-2 variants in wastewater samples

Efficacy and safety of mRNA-based SARS-CoV-2 vaccination in immuno-compromised subjects

Efficacy and safety of mRNA-based SARS-CoV-2 vaccination in immuno-compromised subjects

Seroepidemiologic surveys for assessment of the COVID-19 pandemic in Japan

Seroepidemiologic surveys for assessment of the COVID-19 pandemic in Japan

Nine-month survey of COVID-19 vaccine effectiveness in North Carolina

Nine-month survey of COVID-19 vaccine effectiveness in North Carolina

Study investigates whether immune responses to BNT162b2 vaccine differ in subjects with and without prior SARS-CoV-2 infection

Study investigates whether immune responses to BNT162b2 vaccine differ in subjects with and without prior SARS-CoV-2 infection

New model to identify biological markers in patients with COVID-19 and other illnesses

New model to identify biological markers in patients with COVID-19 and other illnesses

WHO's recommendation provides two new options for treating COVID-19

WHO's recommendation provides two new options for treating COVID-19

UV-C light prevents airborne transmission of SARS-CoV-2

UV-C light prevents airborne transmission of SARS-CoV-2

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

COVID-19 vaccination breakthrough infections in a real-world setting

COVID-19 vaccination breakthrough infections in a real-world setting

Virus-like particles as delivery vehicles for gene-editing

Virus-like particles as delivery vehicles for gene-editing

KHN’s ‘What the Health?’: Dealing with drug prices

KHN’s ‘What the Health?’: Dealing with drug prices

Harmful effects of SARS-CoV-2 infection in pregnant women and their newborns

Harmful effects of SARS-CoV-2 infection in pregnant women and their newborns

Novel biomarker can be used to identify disease progression in ALS

Novel biomarker can be used to identify disease progression in ALS

Exploring factors favoring transmission of SARS-CoV-2 Delta sublineage AY.4.2 over the Delta variant

Exploring factors favoring transmission of SARS-CoV-2 Delta sublineage AY.4.2 over the Delta variant

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.